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ata indicate that estrogen-dependent and -independent pathways are involved in the teratogenic/carcinogenic syndrome that
ollows developmental exposure to 17b-estradiol or diethylstilbestrol (DES), a synthetic estrogen. However, the exact role and
extent to which each pathway contributes to the resulting pathology remain unknown. We employed the aERKO mouse, which
acks estrogen receptor-a (ERa), to discern the role of ERa and estrogen signaling in mediating the effects of neonatal DES
exposure. The aERKO provides the potential to expose DES actions mediated by the second known ER, ERb, and those that are
ER-independent. Wild-type and aERKO females were treated with vehicle or DES (2 mg/pup/day for Days 1–5) and terminated
fter 5 days and 2, 4, 8, 12, and 20 months for biochemical and histomorphological analyses. Assays for uterine expression of the
enes Hoxa10, Hoxa11, and Wnt7a shortly after treatment indicated significant decreases in DES-treated wild-type but no effect
n the aERKO. In contrast, the DES effect on uterine expression of Wnt4 and Wnt5a was preserved in both genotypes, suggesting
developmental role for ERb. Adult aERKO mice exhibited complete resistance to the chronic effects of neonatal DES exposure
xhibited in treated wild-type animals, including atrophy, decreased weight, smooth muscle disorganization, and epithelial
quamous metaplasia in the uterus; proliferative lesions of the oviduct; and persistent vaginal cornification. Therefore, the lack
f DES effects on gene expression and tissue differentiation in the aERKO provides unequivocal evidence of an obligatory role
for ERa in mediating the detrimental actions of neonatal DES exposure in the murine reproductive tract. © 2001 Academic Press
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Laboratory and epidemiological studies have clearly im-
plicated 17b-estradiol (E2) and diethylstilbestrol (DES), en-
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ciences, Laboratory of Reproductive and Developmental Toxicol-224ogenous and synthetic estrogens, respectively, as carcino-
ens and teratogens in humans and laboratory animals
IARC, 1979, 1987; Marselos and Tomatis, 1992, 1993).
eginning in the 1940s, DES was prescribed during preg-
ancy to maintain placental steroid production and thereby
ogy, Receptor Biology Section, MD B3-02, P.O. Box 12233, Re-
search Triangle Park, NC 27709. Fax: (919) 541-0696. E-mail:
korach@niehs.nih.gov.0012-1606/01 $35.00
Copyright © 2001 by Academic Press
All rights of reproduction in any form reserved.
w
p
2
t
(
a
D
s
s
2
m
r
a
T
a
h
l
T
a
c
t
a
E
m
m
s
(
a
l
a
(
t
l
v
t
m
E
t
i
a
d
225Effects of DES in the aERKO Female Mouselessen the risk of spontaneous abortion or preterm parturi-
tion (Marselos and Tomatis, 1992). Despite a 1953 report of
the ineffectiveness of DES for this indication (Dieckmann
et al., 1953), clinical use increased in the years following
(Marselos and Tomatis, 1992). In 1971, following two re-
ports of a causal link between vaginal clear-cell adenocar-
cinoma, a rare cancer, and in utero DES exposure (Green-
ald et al., 1971; Herbst et al., 1971), the U.S. FDA
roscribed the use of DES for pregnancy support (Herbst,
000). To date, DES remains the only drug in which
ransplacental carcinogenesis in man has been proven
Marselos and Tomatis, 1992). More prevalent than cancer
re the multiple teratogenic effects attributed to in utero
ES exposure, including vaginal/cervical epithelial adeno-
is and squamous metaplasia, transverse vaginal ridges, and
tructural malformations of the cervix and uterus (Herbst,
000; Marselos and Tomatis, 1992; Mittendorf, 1995). In
ales, in utero DES exposure is associated with increased
isk of testicular cancer, epididymal cysts, cryptorchidism,
nd testicular hypoplasia (Herbst, 2000; Marselos and
omatis, 1992).
Over the past 30 years, rodent models that effectively
ssimilate the effects of developmental DES exposure in
umans have been thoroughly characterized, yet the under-
ying mechanisms remain poorly understood (Marselos and
omatis, 1992, 1993). It is widely accepted that E2 or DES
exposure during critical developmental periods elicits dis-
tinct and permanent alterations in the Mu¨llerian-derived
structures of the female reproductive tract (oviduct, uterus,
cervix, upper vagina) (Cunha et al., 1991). Interestingly, null
mouse models have illustrated that a lack of estrogen
signaling has little effect on reproductive tract development
(Couse et al., 1999; Couse and Korach, 1999; Fisher et al.,
1998), whereas aberrant estrogen exposure during develop-
ment is detrimental (Cunha et al., 1991). Hence, the under-
lying mechanisms of developmental DES exposure likely
involve its ability to bind the nuclear estrogen receptor (ER)
and mimic the broad spectrum of E2 actions (Korach et al.,
1978, 1989). This aberrant stimulation of estrogen signal-
ing by DES during development may disrupt the proper
expression of estrogen-regulated genes and the ultimate
differentiation/proliferation profile of cell populations. Re-
ported alterations in the expression of Hoxa9, Hoxa10,
Hoxa11 (Block et al., 2000; Ma et al., 1998), and Wnt7a
(Miller et al., 1998a) in the developing murine female
reproductive tract following DES exposure support such a
mechanism. Furthermore, null mouse models of the Hox
(Dolle et al., 1991; Hsieh-Li et al., 1995; Satokata et al.,
1995) and Wnt (Miller et al., 1998a; Parr and McMahon,
1998) gene families exhibit reproductive tract phenotypes
that are comparable to those elicited by developmental DES
exposure. These data support disruption of developmental
gene expression as a mechanism of DES; however, it re-
mains unknown whether this action is dependent on ER.
Further complexity has been introduced by two recent
discoveries: (1) a second nuclear ER (ERb) that exhibits E2-
nd DES-induced in vitro activity comparable to that of theCopyright © 2001 by Academic Press. All rightlassical ER (now termed ERa) (Gigue`re et al., 1998); and (2)
he unique ability of DES to suppress the transactivational
ctivity of the orphan nuclear receptors ERRa, ERRb, and
RRg (Tremblay et al., 2001).
Laboratory studies have also indicated that epigenetic
echanisms, independent of direct interaction with genetic
aterial but leading to permanent changes in gene expres-
ion, may also contribute to the ultimate effects of DES
Liehr, 2000). Perinatal DES exposure in rodents causes
ttenuated uterine responses to subsequent estrogen stimu-
ation during adulthood, characterized as decreased growth
nd secretory activity and altered cellular differentiation
Maier et al., 1985; Medlock et al., 1988, 1992). Similar DES
reatments in mice lead to constitutive up-regulation of
actoferrin expression in adult uteri (Nelson et al., 1994),
seminal vesicle (Beckman et al., 1994), and the urethropros-
tatic complex (Salo et al., 1997). Moreover, Li et al. (1997)
demonstrated distinct alterations in the methylation pat-
tern of the lactoferrin gene promoter in uterine tissue of
mice neonatally exposed to DES, providing support for an
epigenetic pathway by which DES permanently alters gene
expression. Similar changes in gene expression following
neonatal DES exposure are reported for epidermal growth
factor (EGF), EGF-receptor, c-fos, c-jun, c-myc, bax, and
bcl-2 in the reproductive tract of sexually mature mice and
hamsters (Falck and Forsberg, 1996; Nelson et al., 1994;
Zheng and Hendry, 1997). Once again, the role of the ER in
mediating this effect of DES remains unknown.
In contrast to the hormonal and epigenetic mechanisms,
there is evidence of direct genotoxic actions of DES and its
metabolites, presumably independent of ER action. These
mechanisms are more often applied to explain the carcino-
genic properties of DES and include the induction of DNA
adducts, microsatellite instability, sequence deletions or
insertions, and single-strand breaks in both in vitro and in
ivo systems (Liehr, 2000). Furthermore, DES and its me-
abolites are reported to elicit aneuploidy and cell transfor-
ation in Syrian hamster embryo cells lacking measurable
R levels, possibly via interfering with microtubule func-
ion (Tsutsui et al., 1983). Supporting evidence of DES-
nduced genetic instability is provided by descriptions of
neuploid DNA in premalignant vaginal lesions in “DES
aughters” (Welch et al., 1983) and DES-exposed mice
(Hajek et al., 1993).
Therefore, existing evidence supports both ER-dependent
and -independent mechanisms as mediators of the develop-
mental and carcinogenic actions of DES. In this report, we
describe our use of the estrogen receptor-a knockout mouse
(aERKO), which lacks functional ERa, to gain further
insight into the role of this receptor in mediating the effects
of neonatal DES exposure in the female reproductive tract.
In brief, our results demonstrate that adult wild-type mice
neonatally exposed to DES exhibit the previously described
morphological defects throughout the reproductive tract,
whereas their aERKO littermates do not. Furthermore, the
DES-elicited suppression of Hoxa10, Hoxa11, and Wnt7a
expression exhibited in the uteri of treated wild-type mices of reproduction in any form reserved.
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226 Couse et al.shortly after treatment was absent in the aERKO uteri.
These data provide unequivocal evidence of an obligatory
role for ERa in mediating the effects of neonatal DES
exposure in the murine female reproductive tract.
MATERIALS AND METHODS
Generation and Treatment of Animals
All procedures were performed in accordance with the NIH
Guide for the Care and Use of Laboratory Animals and were
preapproved by the NIEHS ICACU. All animals were maintained in
plastic cages under a 12-h light/12-h dark schedule in a
temperature-controlled room (21–22°C), fed NIH 31 mouse chow
and fresh water ad libutum. Mice were generated by breeding
eterozygous (ERa1/2) animals in a continuous mating scheme.
Pregnant mice were single-housed and litters adjusted to 4–8 pups
per dam upon delivery. Pups were treated with DES (Sigma Chemi-
cals, St. Louis, MO) dissolved in corn oil at 2 mg/pup/day (s.c.) for
ays 1–5 (day of birth 5 1); controls were similarly treated with an
qual volume (20 ml) of corn oil. Mice were weaned at 21–22 days
of age and housed 2–4 per cage as described above. Prior to 60 days,
mice were implanted with an implantable microidentification unit
(IMI-1000; BioMedic Data Systems, Seaford, DE) and a tail biopsy
collected for genomic DNA extraction as previously described
(Couse et al., 1994). Mice were selected and terminated at four
predetermined ages designated as I (4–5 months), II (8–9 months),
III (12–13 months), and IV (18–22.7 months). On termination,
whole blood was collected and heparinized and the plasma was
stored at 270°C; all tissues were fixed in 10% buffered formalin.
For gene expression analyses, animals were terminated at 5 days of
age (6 h after the final injection), and at 2–3 months of age, the
reproductive tract was removed quickly and the ovary, oviduct,
uterus, and vagina were separated, snap-frozen, and stored at
270°C. Animals were ERa-genotyped via polymerase chain reac-
tion (PCR) on genomic DNA using the following primers for
detection of an untargeted ERa gene (forward) 59-CGGTCTA-
GGCCAGTCGGGCATC, (reverse) 59-CAGGCCTTACACAGC-
GCCACCC (281-bp amplimer from wild-type ERa exon 2); and
for detection of the gene disruption (forward) 59-GTGTTCC-
GGCTGTCAGCGCA, (reverse) 59-GTCCTGATAGCGGTCCG-
CCA (555-bp amplimer).
Cyto- and Immunohistochemistry
Formalin-fixed tissues were paraffin-embedded and 6 mm sec-
tions mounted on ProbeOn Plus slides (Fisher Scientific, Pitts-
burgh, PA). Sections were stained with hematoxylin and eosin
(H&E) for routine light microscope evaluation. Immunohistochem-
istry for ERa was performed as follows. Following standard depar-
ffinization and hydration protocol, endogenous peroxidase was
uenched by incubation in 3% H2O2 and antigen retrieval carried
out in 13 citrate buffer in a decloaking chamber (BioCare Medical,
Walnut Creek, CA) according to the manufacturer’s protocol. All
washes were carried out in 13 Automation Buffer (AB) (Biomeda
Corporation, Foster City, CA). Sections were blocked with 5%
normal horse serum (Jackson ImmunoResearch Laboratories, West
Grove, PA) followed by incubation with a 1:50 dilution of mono-
clonal anti-ERa antibody (ER1D5) for 1 h (Beckman Coulter, Brea,
A), washed in 13 AB, and incubated with a 1:500 dilution of
iotinylated horse anti-mouse IgG antibody (Vector Laboratories,
urlingame, CA). Specific immunoreactivity was detected usingCopyright © 2001 by Academic Press. All righthe Vectastain ABC Kit (Vector Laboratories) according to the
anufacturer’s protocol using 3,39-diaminobenzidine tetrahydro-
hloride as a chromogen, followed by counterstain with hematoxylin.
Cloning of the Wnt4 and Wnt5a cDNA
Probe Templates
Riboprobe templates for the mouse Wnt4 and Wnt5a consisted
of a reverse transcription–PCR generated (RT-PCR) cDNA frag-
ment cloned into the pCRII-TOPO vector (Invitrogen, Carlsbad,
CA) according to the manufacturer’s protocol. The Wnt4 template
consisted of 426 bp of the mouse Wnt4 cDNA (bp 230–655,
GenBank Accession Number M89797) amplified from C57BL/6
ovary RNA using the following primers: (forward) 59-AGG-
TGATGGACTCAGTGCGC, (reverse) 59-CCCGCATGTGTGTC-
AAGATG. The Wnt5a template consisted of 253 bp of the mouse
nt5a cDNA (bp 609–861, GenBank Accession Number M89798)
mplified from C57BL/6 lung RNA using the following primers:
forward) 59-CCATGTCTTCCAAGTTCTTCC, (reverse) 59-CAT-
CCTTGATGCCTGTCTTC. All clones were confirmed by se-
uence analysis.
Total RNA Isolation, RNase Protection Assay,
and in Situ Hybridization
Total RNA was isolated using Trizol reagent (Life Technologies,
Rockville, MD) according to the manufacturer’s protocol. Concen-
trations of the final preparations were calculated from an A260
reading (Beckman DU-7 spectrophotometer) and an aliquot ana-
lyzed by gel electrophoresis to ensure integrity. Radiolabeled
antisense riboprobes for ribonuclease protection assays (RPAs)
were generated from linearized vectors using the Ambion Maxi-
Script Kit (Ambion, Austin, TX) and [32P]CTP (Amersham Pharma-
ia Biotech, Piscataway, NJ) according to the manufacturer’s pro-
ocol. Wnt4 and Wnt5a antisense riboprobes were generated from
he templates described herein; Hoxa10 and Hoxa11 antisense
iboprobes were described previously (Benson et al., 1995; Hsieh-Li
t al., 1995; Ma et al., 1998). The Hoxa10 antisense riboprobe
differentially detects the splice variants Hoxa10-1 and Hoxa10-2
(Benson et al., 1995). A cyclophilin antisense riboprobe was gener-
ated from the pTRI–cyclophilin template (Ambion) and included in
all assays for normalization. Sizes (nt) of the respective protected
fragments were as follows: cyclophilin 5 103, Wnt4 5 426,
Wnt5a 5 253, Hoxa10-1 5 316, Hoxa10-2 5 146, and Hoxa 11 5
37. RPAs were carried out on total RNA from tissue of individual
nimals using Hybspeed RPA reagents (Ambion) according to the
anufacturer’s protocol. All RPA samples were fractionated by
lectrophoresis on precast 6% bis-acrylamide/7 M urea/13 Tris–
orate gels (Invitrogen), which were then fixed, dried, and exposed
o a phosphorimager screen followed by analysis with a Storm 860
nd ImageQuant Software (Molecular Dynamics, Sunnyvale, CA).
In situ hybridization for Hoxa10 mRNA in the neonatal uteri
as carried out as previously described (Ma et al., 1998), using the
bove-described antisense riboprobe labeled with digoxigenin.
Semiquantitative RT-PCR for Wnt7a
Repeated assays indicated the levels of Wnt7a mRNA in the
neonatal uterus to be below the levels of reproducible detection by
RPA. Therefore, the following semiquantitative RT-PCR protocol
was carried out for these analyses. PCR for Wnt7a and b-actin
transcripts was simultaneously carried out on cDNA preparations
from total RNA from tissue of individual animals. Primers fors of reproduction in any form reserved.
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227Effects of DES in the aERKO Female MouseWnt7a mRNA detection amplified a 302-bp fragment (bp 539–840,
GenBank Accession Number M89801): (forward) 59-TGAACTT-
ACACAATAACGAGGC, (reverse) 59-CTCTTCACAGTAATT-
GGGTGAC. Primers for detection of the mouse b-actin mRNA
ere purchased from Clontech (Palo Alto, CA). RT generation of
DNA was carried in a reaction of 2.5 mM random hexamers
(Applied Biosystems, Foster City, CA), 0.2 mM (d)-NTPs each
(Invitrogen), 25 U RNase inhibitor (Applied Biosystems), 62.5 U
MuLV reverse transcriptase (Applied Biosystems), and 0.5 mg of
total RNA in a volume of 25 ml. Semiquantitative PCR reactions
for each cDNA preparation were prepared as follows: 60 ml reaction
consisting of 13 Optimized PCR buffer F (Invitrogen), 8.0 ml cDNA
preparation, 50 pmol of each Wnt7a primer, 5 pmol of each b-actin
primer, 0.2 mM each deoxy (d)-NTPs (Invitrogen), and 3 U Plati-
numTaq DNA polymerase (Life Technologies). This was then
aliquoted at 15 ml per reaction to generate four identical reactions
er cDNA preparation, one for each of the four PCR termination
ime points (20, 25, 30, and 35 cycles). Thermal cycling conditions
onsisted of an initial 95°C/2 min, 95°C/30 s, 58°C/45 s, 72°C/30 s,
nd 72°C/7 min in a GeneAmp 9600 Thermal Cycler (Applied
iosystems). This process was carried out in duplicate for each
DNA preparation.
All samples were electrophoresed in a gel of 13 TBE/2% Nu-
eive Agarose/0.7% SeaKem Agarose (FMC Bioproducts, Rockland,
E), which was then transferred to BrightStar Nylon membrane
Ambion) according the manufacturer’s protocol. All blots were UV
rosslinked (UV Stratalinker 1800; Stratagene, La Jolla, CA). For
uantitation, blots were probed with oligos complementary to
equences nested within the RT-PCR primers and consisted of the
ollowing oligos and their complements, which when annealed
enerated flanking 10-bp overlaps (indicated by “/”): Wnt7a,
9-GTCGAAACAA/GCGGCCCACCTTTCTGAAGA/TCAAGA-
GCC (bp 731–770, GenBank Accession Number M89801); b-actin,
9-GCCCATCTAC/GAGGGCTATGCTCTCCCTCA/CGCCATC-
TG (bp 411–450, GenBank Accession Number M12481). The
verlapping sequences were filled-in in the presence of [32P]dCTP
(Amersham Pharmacia Biotech) using Klenow DNA polymerase
(Life Technologies) according the manufacturer’s protocol. All
hybridizations were carried out for 12–18 h at 55°C in a solution of
13 SSC, 0.2 M NaH2PO4, 53 Denhardt’s solution, 0.1% SDS, 0.5
g/ml salmon-sperm DNA, and .1.0 3 108 cpm of each probe.
Following hybridization, blots were washed at room temperature in
63 SCC followed by 0.5% SDS/0.13 SSC at 55°C at 30 min per
ash; then exposed to a phosphorimager screen followed by anal-
sis with a Storm 860 and accompanying ImageQuant Software
Molecular Dynamics).
Plasma E2 Radioimmunoassay (RIA)
Serum E2 was assayed on 200 ml aliquots per animal using the
ultrasensitive 17b-estradiol double-antibody [125I]RIA (Diagnostic
Systems Laboratories, Webster, TX) according to the manufactur-
er’s protocol and counted on a Packard Multi-Prias 2 Gamma
Counter.
Statistical Analysis
All data sets were first tested for homoscedasticity of variance
using the Levine’s test. In cases where data were found to lack
homoscedasticity of variance (P , 0.05), all data were log-transformed
rior to further statistical analysis. In all cases, data sets were analyzed
y two-way ANOVA followed by individual post hoc comparisons.
tatistical significance was assigned at P , 0.05.Copyright © 2001 by Academic Press. All rightRESULTS
The acute effects of DES exposure on developmental gene
expression were assessed via analysis of mRNA levels for
Hoxa10, Hoxa11, Wnt4, Wnt5a, and Wnt7a in uterine
tissue collected on neonatal Day 5, approximately 6–8 h
after the final treatment. As shown in Fig. 1, DES exposure
elicited a significant decrease in the uterine levels of
mRNAs encoding Hoxa10-1 (P , 0.01) and Hoxa11 (P ,
0.01) in the wild-type neonate when compared to that of
corn oil-treated controls. In contrast, uterine tissues from
aERKO neonates failed to exhibit this effect of DES expo-
sure and possessed Hoxa10-1 and Hoxa11 mRNA levels in
both treatment groups that were comparable to that of the
corn oil-treated wild-type. These results were corroborated
by whole-mount in situ hybridization for Hoxa10, as shown
in Fig. 1b. There was no effect of genotype or treatment on
the levels of Hoxa10-2 transcripts, a previously described
splice variant of the mouse Hoxa10 gene with unknown
function (Benson et al., 1995) (Fig. 1).
The results of similar assays for Wnt7a, Wnt4, and Wnt5a
transcripts in neonatal uterine tissue following corn oil or
DES treatment are shown in Figs. 2 and 3, respectively. A
striking effect of DES exposure in the neonatal uterus was
an over 80% decrease in Wnt7a mRNA levels compared to
that of corn oil-treated controls (P , 0.01) (Fig. 2). However,
once again this effect of DES was exhibited only in the
wild-type neonates and completely lacking in the DES-
treated aERKO. In contrast to Wnt7a, the observed effects
of DES on uterine expression of the Wnt4 and Wnt5a genes
were observed in both wild-type and aERKO mice (Fig. 3).
DES treatment elicited a significant decrease in uterine
Wnt4 mRNA levels that exceeded 50% (P , 0.01) in the
ild-type, while a less-robust decrease was observed in the
ES-treated aERKO mice. Interestingly, the basal levels of
nt4 transcripts in the uteri of the neonatal control
aERKO mice were increased compared to that of the
wild-type, and although reduced following DES treatment,
the ultimate levels of Wnt4 mRNA in the DES-treated
aERKO uteri remained similar to that of the corn oil-
treated wild-type. In contrast to the reducing effect of DES
on Wnt4 expression, a trend toward increased uterine
expression of Wnt5a was observed in the DES-treated
wild-type (P , 0.1) and aERKO neonates (P , 0.05).
The permanent nature of the acute effects of neonatal
DES exposure on Hoxa10, Hoxa11, Wnt4, Wnt5a, and
Wnt7a expression in the uterus was assessed on tissue
collected from sexually mature females (2–3 months) that
were exposed to either corn oil or DES as neonates. The
DES-elicited reduction in Hoxa10–1 expression observed in
the uteri of neonatal wild-type mice appeared to persist
during sexual maturity, although it was no longer statisti-
cally significant (Fig. 4). Once again the uterine levels of
Hoxa10–1 mRNA in the adult aERKO females of both
reatment groups were within the wild-type control range
nd showed no effect of neonatal DES exposure. In contrast
o the apparent permanent effect of DES exposure ons of reproduction in any form reserved.
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228 Couse et al.Hoxa10 expression in the uterus, the acute effects of DES
observed on Hoxa11, Wnt4, Wnt5a, and Wnt7a expression
were no longer apparent in the adult animals of either
genotype (data not shown).
The long-term morphological effects of neonatal DES
exposure on the reproductive tract of wild-type and aERKO
emales are summarized in Tables 1 and 2 and illustrated in
ig. 5. A well-characterized effect of neonatal DES exposure
n rodents is a permanent attenuation of the estrogen-
nduced growth in the uterus, best illustrated as chronically
educed uterine weight exhibited by DES-treated females
elative to that of age-matched controls (Maier et al., 1985;
edlock et al., 1988). Herein, this effect was replicated in
FIG. 1. Neonatal DES treatment reduces Hoxa10 and Hoxa11 expr
ribonuclease protection assays (RPA) for Hoxa10 (splice variants -1
rom animals at 5 days of age, approximately 6 h after the final cor
cyc) mRNA were carried out for normalization. (b) Whole-mount
5-day-old wild-type and aERKO mice following treatment with co
RPAs, showing the average percentage of cyclophilin (6 SEM) for ea
5; wild-type-DES, n 5 5; aERKO-CO, n 5 6; aERKO-DES, n 5 6.Copyright © 2001 by Academic Press. All rightthe DES-exposed wild-type mice at all time points, reaching
statistical significance (P , 0.01) at age groups II–IV (Table
1). Estrogen resistance in the uterus is innate to the aERKO
mice (Couse and Korach, 1999), and no exacerbation of this
phenotype was observed after DES treatment (Table 1). An
additional observation was an increased body weight in
DES-treated wild-type females compared to that of corn
oil-treated controls (Table 1), attributed predominantly to
an excessive accumulation of white adipose tissue in the
inguinal and perimetrial fat pads. This DES effect was most
apparent in the treated wild-type mice of the I and II age
groups (P , 0.01), whereas age-related increases in body
weight in the control groups lessened the difference at the
n in the uteri of wild-type but not aERKO mice. (a) Representative
-2) and Hoxa11 on 2 mg total RNA from individual uteri collected
(CO) or diethylstilbestrol (DES) treatment. Assays for cyclophilin
itu hybridization for Hoxa10 mRNA in the reproductive tracts of
l (CO) or diethylstilbestrol (DES). (c) Quantitative analysis of the
perimental group. Sample sizes were as follows: wild-type-CO, n 5
0.01.essio
and
n oil
in s
rn oi
ch ex
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229Effects of DES in the aERKO Female Mouselatter time points. Consistent with previous descriptions,
aERKO mice of both treatment groups exhibited elevated
average body weights compared to that of wild-type females
(Couse and Korach, 1999; Heine et al., 2000), and at no time
exhibited a difference between treatment groups (Table 1).
Therefore, neonatal DES exposure results in an attenuation
of the physiological effects of estrogen action in the uterus
and abdominal white adipose tissue in wild-type mice,
resulting in a phenotype in each of these tissues that
partially mimics the innate effect of ERa gene disruption
xhibited by the aERKO female.
As shown in Table 2 and Fig. 5, DES-treated wild-type
ice exhibited a relatively high frequency of the multiple
eproductive tract lesions known to be associated with
eonatal DES exposure. In the uterus, these included atro-
hy (61%), disorganization of the smooth muscle (87%),
FIG. 2. Neonatal DES treatment reduces Wnt7a expression in the
uteri of wild-type but not aERKO mice. (a) A representative
Southern blot of semiquantitative RT-PCR for Wnt7a mRNA from
individual uteri collected from animals at 5 days of age, approxi-
mately 6 h after the final corn oil (CO) or diethylstilbestrol (DES)
treatment. Assays for b-actin mRNA were carried out for normal-
zation. (b) Quantitative analysis of the semiquantitative RT-PCR
eported as the average percentage of b-actin (6 SEM) for each
xperimental group. Sample sizes were as follows: wild-type-CO,
5 5; wild-type-DES, n 5 5; aERKO-CO, n 5 6; aERKO-DES, n 5
. All data shown are from samples collected after 25 PCR cycles.
*P , 0.01.Copyright © 2001 by Academic Press. All rightyalinization (90.9%), squamous metaplasia of the luminal
nd glandular epithelium (46.8%), and endometrial hyper-
lasia (24.1%). Among the types of uterine lesions observed,
nly endometrial hyperplasia was also observed in corn
il-treated wild-type groups (56%). Immunohistochemical
etection of ERa in a squamous metaplasia of the uterine
epithelium from a DES-treated wild-type female (Figs. 5m–
5o) indicates the potential of this lesion to respond to
endogenous estrogens. In the vagina, DES-exposed wild-
type mice exhibited a 100% incidence of persistent epithe-
lial cornification (Figs. 5j–5l) and a 2.5% incidence of
vaginal adenosis, compared to an absence of these lesions in
corn oil-treated wild-type females. In the oviduct, progres-
sive proliferative lesions of the epithelium, a well-
characterized lesion strongly associated with neonatal DES
exposure in rodents (Newbold et al., 1985), was observed at
an incidence of 94.5% in DES-exposed wild-type females
(Figs. 5a–5c) compared to 0% in corn oil-treated controls. In
stark contrast to the pathology observed in the reproductive
tract tissues of DES-exposed wild-type females was a com-
plete lack of incidence of these same lesions in similarly
treated aERKO mice (Table 2). Tissues collected from
ES-exposed aERKO females of all four age groups ap-
peared similar at both the gross and microscopic levels to
those collected from corn oil-treated aERKO females and
exhibited none of the characteristic effects of neonatal DES
exposure (Fig. 5). Lesions that appeared to be unique to the
aERKO mice were those previously described and attrib-
uted to the loss of ERa function (Couse and Korach, 1999),
including uterine hypoplasia and uncornified vaginal epi-
thelium (Table 2). Neonatal DES exposure resulted in no
observable effect on these phenotypes.
The only lesion type found to be common between the
DES-treated wild-type and aERKO mice was the presence of
cystic follicles in the ovary, a condition likely related to
DES exposure in the wild-type (Newbold, 1995) but innate
to the adult aERKO female (Couse and Korach, 1999).
ypertrophy of the interstitium was observed in 97.5% of
ES-exposed wild-type mice compared to a 12% incidence
n corn oil-treated controls. However, neonatal DES expo-
ure had no profound effect on the basal levels of serum E2
in the wild-type and aERKO mice (Table 3). Consistent
with previous descriptions of the aERKO female (Couse and
Korach, 1999), serum E2 levels were elevated compared to
hat of wild-type at all time points, regardless of neonatal
reatment (Table 3). Therefore, any possible ligand-
ependent signaling pathways of ERb are presumed to be
intact in both genotypes and treatment groups.
DISCUSSION
Despite decades of research, the mechanisms by which
developmental exposure to estrogens results in permanent
alterations in the growth, differentiation, and function of
reproductive tract tissues in rodents and man remain un-
clear. Studies to date indicate that both estrogen-dependent
and -independent pathways are likely involved in the tera-s of reproduction in any form reserved.
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Copyright © 2001 by Academic Press. All righttogenic and carcinogenic syndrome that occurs in the
reproductive tract following developmental exposure to E2,
DES, or other estrogenics (Liehr, 2000). However, the exact
role of the estrogen-dependent and -independent pathways,
and the extent to which each contributes to the resulting
pathology remains unknown. We employed the aERKO
female mouse to gain insight into the role of this receptor
and that of the estrogen signaling system in mediating the
effects of neonatal DES exposure. Use of the aERKO mouse
provides the potential to expose DES actions that are
mediated by ERb or other receptors as well as those actions
hat are independent of receptor-mediated estrogen signal-
ng. Our results provide unequivocal evidence of an obliga-
ory role for ERa in mediating the effects of neonatal DES
FIG. 4. Neonatal DES treatment leads to permanently reduced
Hoxa10 expression in the uteri of adult wild-type but not aERKO
ice. (a) A representative ribonuclease protection assay (RPA) for
oxa10 (splice variant -1) on 5 mg total RNA from individual uteri
collected from animals at 2–3 months of age, following neonatal
exposure to corn oil (CO) or diethylstilbestrol (DES). Assays for
cyclophilin (cyc) mRNA were carried out for normalization. (b)
Quantitative analysis of the RPAs shows the average percentage of
cyclophilin (6 SEM) for each experimental group. Sample sizes
were as follows: wild-type-CO, n 5 5; wild-type-DES, n 5 6;
aERKO-CO, n 5 5; aERKO-DES, n 5 4. ns, not statistically
significant.FIG. 3. Neonatal DES treatment effects Wnt4 and Wnt5a expres-
ion in the uteri of both wild-type and aERKO mice. (a) Represen-
tative ribonuclease protection assays (RPAs) for Wnt4 and Wnt5a
n 2 mg total RNA from individual uteri collected from animals at
5 days of age, approximately 6 h after the final corn oil (CO) or
diethylstilbestrol (DES) treatment. Assays for cyclophilin (cyc)
mRNA were carried out for normalization. (b) Quantitative analy-
sis of the RPAs shows the average percentage of cyclophilin
(6 SEM) for each experimental group. Sample sizes were as follows:
wild-type-CO, n 5 5; wild-type-DES, n 5 5; aERKO-CO, n 5 6;
aERKO-DES, n 5 6. *P , 0.05; ns, not statistically significant.s of reproduction in any form reserved.
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231Effects of DES in the aERKO Female Mouseexposure in the developing murine female reproductive
tract.
The sensitivity of the developing female reproductive
tract to the detrimental effects of DES has been well
documented (Marselos and Tomatis, 1993). The complete
lack of DES effects in the aERKO female indicate this
ensitivity is the result of the high levels of ERa present in
these tissues during late fetal and neonatal development
(Greco et al., 1993; Korach et al., 1988; Yamashita et al.,
989). None of the DES-exposed aERKO females, including
nimals exceeding 22 months of age, exhibited the distinct
bnormalities that were apparent in DES-treated wild-type
emales. This included the absence of several lesions char-
cteristic of neonatal DES exposure, such as progressive
roliferative lesion of the oviduct (Newbold et al., 1985);
ecreased weight, atrophy, smooth muscle disorganization,
nd epithelial squamous metaplasia in the uterus (New-
old, 1995); and persistent cornification of the vaginal
pithelium (Takasugi, 1976). Therefore, the absence of
ES-induced abnormalities in the reproductive tract of the
aERKO supports a predominant role of ERa in mediating
the detrimental effects of DES in female reproductive tract
development. The lack of apparent ERb-mediated effects of
neonatal DES exposure, despite the presence of elevated
levels of endogenous E2, is consistent with previous diffi-
ulty in detecting ERb mRNA or protein in uterine, ovi-
duct, and vaginal tissue of newborn and adult mice (Couse
et al., 1997b; Jefferson et al., 2000).
Recent molecular studies have begun to provide clues as
o the mechanisms by which developmental DES exposure
TABLE 1
Sample Number and Whole Body and Uterine Weights in Adult W
Following Neonatal Exposure to Corn Oil or Diethylstilbestrol (D
Treatment group I
Sample number
WT—corn oil 12
WT—DES 12
aERKO—corn oil 11
aERKO—DES 9
Body weightb (g)
WT—corn oil 23.3 (0.4) 2
WT—DES 32.8 (2.1)** 3
aERKO—corn oil 28.7 (0.9)† 3
aERKO—DES 30.5 (1.2) 3
Uterine weightb,c
WT—corn oil 0.42 (0.04) 0
WT–DES 0.30 (0.04) 0
aERKO—corn oil 0.26 (0.05) 0
aERKO—DES 0.28 (0.03) 0
a Age groups (months): I 5 4–5, II 5 8–9, III 5 12–13, IV 5 18–2
b Data shown for body weight and uterine weight are average (S
c Uterine weight reported as percentage of body weight.
* P , 0.05, **P , 0.01; corn oil vs DES within the same geno
† P , 0.05, ††P , 0.01; wild-type vs aERKO within the sameCopyright © 2001 by Academic Press. All righteads to its syndrome of defects in the female reproductive
ract. Considerable efforts have focused on the clustered
omeobox genes Hoxa10 and Hoxa11, both of which are
xpressed in the paramesonephric ductal segments of the
u¨llerian duct that ultimately differentiate into the uterus
nd cranial cervix (Kitajewski and Sassoon, 2000; Taylor et
l., 1997). The developmental expression pattern of Hoxa10
nd Hoxa11 is highly conserved in mice and humans
Taylor et al., 1997), the importance of which has been
ffectively illustrated by studies of null mice. Hoxa10 null
ice exhibit a partial anterior homeotic transformation in
hich the anterior 25% of the uterus resembles the struc-
ural and molecular characteristics of the oviduct (Benson
t al., 1996); Hoxa11 null mice exhibit thinner, shorter
terine horns with a paucity of glands (Gendron et al.,
997). These phenotypes in Hoxa10 and Hoxa11 null mice
re somewhat similar to those described in mice following
evelopmental DES exposure (Kitajewski and Sassoon,
000). Therefore, a potential mechanism of DES may in-
olve alterations in the developmental program required for
roper uterine differentiation (Block et al., 2000; Kitajewski
nd Sassoon, 2000; Ma et al., 1998). By 6 h after the final
eonatal DES treatment, a significant reduction in Hoxa10
nd Hoxa11 expression of .50% was observed in the uteri
f wild-type mice, consistent with previous reports (Block
t al., 2000; Ma et al., 1998). Based on reported gene–dosage
ffects following targeted disruption of the Hoxa11 and
oxa13 genes (Hsieh-Li et al., 1995; Warot et al., 1997), this
evel of reduction in gene expression could ostensibly elicit
n aberrant phenotype. More important, our studies illus-
ype (WT) and aERKO Mice
Age groupa
I III IV
19 18
27 20
9 9
15 10
.5) 29.1 (1.2) 31.6 (1.2)
.2)** 34.1 (1.0) 36.3 (2.1)
.2)†† 31.1 (1.7) 32.1 (2.0)
.4) 34.6 (2.0) 30.4 (1.9)
.05) 0.65 (0.08) 0.93 (0.14)
.02)** 0.26 (0.02)** 0.44 (0.09)**
.01)†† 0.20 (0.06)†† 0.33 (0.07)†
.03) 0.20 (0.06) 0.20 (0.04)
.
ment.ild-T
ES)
I
23
27
10
14
5.1 (0
2.3 (1
3.8 (1
1.6 (1
.46 (0
.23 (0
.09 (0
.15 (0
2.7.
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232 Couse et al.FIG. 5. Characteristic morphological effects of neonatal DES exposure occur in the reproductive tract tissues of adult wild-type but not
aERKO. (a–l) Photomicrographs of H&E-stained tissue sections from representative wild-type corn oil (WT-CO; a, d, g, j), wild-type DES
(WT-DES; b, e, h, k, m), and aERKO-DES (c, f, i, l) females of the 8–9 months age group. (a–c) Sections of oviduct from WT-CO (a), WT-DES
b), and aERKO-DES (c) females, illustrating the progressive proliferative lesions characteristic of neonatal DES exposure that occurs only
n the exposed wild-type (compare b to a and c). This lesion is characterized by hyperproliferation of the oviductal epithelium, resulting in
he formation of glands (arrows) within the duct. Low-magnification (d–f) and high-magnification (g–i) of sections of uterus from WT-COCopyright © 2001 by Academic Press. All rights of reproduction in any form reserved.
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233Effects of DES in the aERKO Female Mousetrate that the action of DES on Hoxa10 and Hoxa11
xpression in the neonatal uterus is dependent on the
resence of a functional ERa.
The reducing effect of neonatal DES exposure on uterine
Hoxa10 expression remained detectable during adulthood
(Fig. 4) and is possibly significant, considering the critical
role of Hoxa gene expression in implantation and pregnancy
(Benson et al., 1996; Hsieh-Li et al., 1995; Lim et al., 1999).
Furthermore, aberrant uterine Hoxa10 and Hoxa11 expres-
sion is reported in women with endometriosis (Taylor et al.,
1999). Although an association between in utero DES
exposure and reduced fertility or endometriosis in humans
remains controversial (Golden et al., 1998), these data
warrant further study of uterine HOX gene expression in
DES daughters.
Previous studies have provided indirect evidence of ste-
roid receptor-mediated regulation of Hoxa10 and Hoxa11
expression in the mouse and human uterus (Block et al.,
2000; Ma et al., 1998; Taylor et al., 1998). Furthermore,
multiple consensus binding sites for the ER and progester-
one receptor are present in the known genomic sequences
of Hoxa10 and Hoxa11 (Ma et al., 1998). However, whereas
Ma et al. (1998) reported that E2 continues to reduce
Hoxa10 expression in the adult mouse uterus, Taylor and
colleagues (Block et al., 2000; Taylor et al., 1998) report a
stimulatory effect of DES and E2 in multiple in vitro
ystems but no discernable effect in human endometrial
issue during periods of elevated serum estrogens (Taylor et
l., 1998). Herein, no misregulation of Hoxa10 expression
in the uteri of adult aERKO mice was observed, despite the
presence of elevated plasma E2. Therefore, our data indicate
hat estrogen regulation of Hoxa10 and Hoxa11 expression
in both the neonatal and adult uterus is predominantly
dependent on the presence of functional ERa.
In addition to the homeobox genes, Wnt gene products
also play critical roles in the regulation of tissue patterning
during embryogenesis and adulthood (Kitajewski and Sas-
soon, 2000). At 6 days of age in the mouse uterus, Wnt4
expression is limited to the mesenchyme nearest the lu-
men, Wnt5a is limited to the stroma, and Wnt7a appears in
the luminal and glandular epithelium (Miller et al., 1998b).
Targeted deletion of the Wnt7a gene in mice results in a
multitude of uterine phenotypes that resemble the effects
of neonatal DES exposure (Kitajewski and Sassoon, 2000),
including a disorganized myometrium, reduced uterine
(d, g), WT-DES (e, h), and aERKO-DES (f, i) females, illustrating the e
luminal and glandular epithelium (short arrows) and disorganizatio
were apparent only in the WT-DES (e and h). Uterine tissue from aE
hypoplasia of the smooth muscle, endometrial stroma, and glandu
vagina from WT-CO (j), WT-DES (k), and aERKO-DES (l) female
eonatal DES exposure that occurs only in the exposed wild-type (c
exhibited an uncornified vaginal epithelium, a phenotype innate to
uterine epithelium of a WT-DES female, stained with H&E (m
immunoreactivity in the cells of the epithelial lesion and underlyi
which the ERa antibody was excluded during immunohistochemiCopyright © 2001 by Academic Press. All rightdiameter, absence of glands, and a stratified vaginal-like
epithelium rather than the simple columnar epithelium
characteristic of the normal uterus (Parr and McMahon,
1998). As with the Hoxa genes, DES elicits an acute
reduction in Wnt7a expression of almost 90% in the neo-
natal wild-type mouse uterus (Fig. 2). These data are con-
sistent with a previously reported effect of prenatal DES
exposure on Wnt7a expression (Miller et al., 1998a). More
important, the lack of a DES-elicited reduction in Wnt7a
expression in the aERKO uteri provides definitive evidence
of the requirement for ERa in this mechanism. Therefore, it
s likely that the loss of ERa function in the aERKO female
prevents the aberrant developmental defects of DES in the
reproductive tract by allowing for normal expression of
Hoxa10, Hoxa11, and Wnt7a.
The preservation of two immediate effects of DES in the
neonatal aERKO uterus, decreased Wnt4 and increased
Wnt5a expression, suggests the existence of ERa-
independent DES-activated pathways. A likely candidate
for the maintenance of certain hormonal actions of DES in
the aERKO uterus is ERb, although it remains difficult to
detect ERb mRNA or protein in uterine tissue of newborn
ice (Jefferson et al., 2000). Also possible is the activation
f apparent ER-independent pathways in the uterus, such as
hose reported in ovariectomized aERKO females following
treatment with 4-hydroxy-E2, methoxychlor, or kepone
(Das et al., 1997; Ghosh et al., 1999). The recent report by
Tremblay et al. (2001) that DES, and not E2, specifically
nteracts with and suppresses the transactivational activity
f the estrogen-related receptors ERRa, -b, and -g presents
the possibility that these receptors may also be involved in
Wnt4 and Wnt5a regulation. Nonetheless, the effects of
DES on the uterine Wnt4 and Wnt5a expression were
ransient, given that normal mRNA levels were detected in
he adult wild-type and aERKO mice.
Decreased uterine weight in sexually mature females is a
characteristic effect of neonatal DES exposure in the rodent
and is attributed to an attenuation of the uterine estrogen
response resulting from constitutive reduction in ER levels
(Maier et al., 1985; Medlock et al., 1988, 1992). Similarly,
the prostate of the neonatal estrogenized rat exhibits re-
duced androgen receptor levels and an attenuated response
to endogenous androgens, leading to reduced prostate
weight in the adult (Prins, 1992; Prins and Birch, 1995).
Herein, neonatal DES-exposed wild-type females exhibited
s of neonatal DES exposure in the uterus, including an estrogenized
alinization of the inner circular smooth muscle (long arrows) that
-DES (f, i) exhibited no effects of neonatal DES exposure, but only
pithelium, a phenotype innate to the loss of ERa. (j–l) Sections of
lustrating the excessive epithelial cornification characteristic of
re k to j and l). This effect was absent in the aERKO-DES (l), which
oss of ERa. (m–o) Illustration of early squamous metaplasia in the
immunostained for ERa (n), illustrating specific nuclear ERa
roma (indicated by arrows). (o) Represention of a serial section in
nd therefore serves as a negative control.ffect
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234 Couse et al.a reduced average uterine weight throughout adulthood
that was somewhat comparable to that of the innate phe-
notype of the aERKO mice (Table 1). Therefore, neonatal
DES exposure partially mimics the effect of ERa gene
disruption in the murine uterus. Estrogen resistance attrib-
uted to developmental DES exposure also appeared to occur
in the regulation of white adipose tissue. Sexually mature
wild-type females neonatally exposed to DES exhibited an
excessive accumulation of abdominal white adipose tissue
TABLE 2
Incidence of Pathology Observed in Wild-Type and aERKO Femal
Tissue/Lesion
Wild-
I II
terus
Hypoplasia 0/12 0/27
Atrophy 0/12 22/26
Disorganization of smooth muscle 10/10 26/26
Hyalinization 10/10 25/26
Squamous metaplasia 3/10 9/26
Endometrial hyperplasia 0/12 2/26b
Stromal sarcoma 0/12 0/26
Vagina
Persistent cornification 10/10 26/26
No cornification 0/10 0/26
Adenosis 0/12 2/26
Ovary
Interstitial hypertrophy 11/12e 27/27f
Cystic follicle(s) 5/12e 20/27i
Granulosa cell tumor 0/12 0/27
Tubulostromal adenoma 0/12 0/27
Oviduct (PPL)
Stage 1 5/12 1/23
Stage 2 3/12 11/23
Stage 3 3/12 9/23
Stage 4 0/12 2/23
Total 11/12 23/23
Notes. Age groups are the same as in Table 1. Unless otherwise n
enotype. PPL, progressive proliferative lesion; stages represent lev
a Exhibited in 100% of corn oil-exposed mice of the same genot
b Exhibited in 8 of 23 corn oil-exposed wild-type mice.
c Exhibited in 13 of 19 corn oil-exposed wild-type mice.
d Exhibited in 9 of 12 corn oil-exposed wild-type mice.
e Exhibited in 1 of 12 corn oil-exposed wild-type mice.
f Exhibited in 1 of 23 corn oil-exposed wild-type mice.
g Exhibited in 3 of 19 corn oil-exposed wild-type mice.
h Exhibited in 3 of 12 corn oil-exposed wild-type mice.
i Exhibited in 2 of 23 corn oil-exposed wild-type mice.
j Exhibited in 1 of 19 corn oil-exposed wild-type mice.
k Exhibited in 2 of 12 corn oil-exposed wild-type mice.
l Exhibited in 6 of 8 corn oil-exposed aERKO mice.
m Exhibited in 3 of 4 corn oil-exposed aERKO mice.
n Exhibited in 1 of 10 corn oil-exposed aERKO mice.
o Exhibited in 4 of 8 corn oil-exposed aERKO mice.
p Exhibited in 4 of 9 corn oil-exposed aERKO mice.Copyright © 2001 by Academic Press. All rightnd subsequent increases in whole body weight (Table 1).
emarkably similar increases in white adipose tissue and
ody weight are innate to the aERKO female, as observed
here and recently reported by Heine et al. (2000). Further-
more, increases in white adipose tissue and body weight
occur in rodents following postnatal ovariectomy (Dukes et
al., 1994; Sibonga et al., 1998) or targeted disruption of the
cyp19 gene and subsequent loss of E2 synthesis (Jones et al.,
000), supporting an inhibitory role for ERa in adipogenesis.
e Following Neonatal DES Exposure
aERKO
III IV I II III IV
/25 0/16 9/9a 14/14a 15/15a 9/9a
/25 13/16 0/9 0/14 0/15 0/9
/25 10/16 0/9 0/14 0/15 0/9
/25 12/16 0/9 0/14 0/15 0/9
/25 2/16 0/9 0/14 0/15 0/9
/25c 7/16d 0/9 0/14 0/15 0/9
/25 1/16 0/9 0/14 0/15 0/9
/25 16/16 0/9 0/14 0/15 0/9
/25 0/16 8/8a 13/13a 15/15a 9/9a
/25 0/16 0/9 0/14 0/15 0/9
/24g 15/16h 0/9 0/14 0/15 0/9
/25j 2/16k 9/9a 14/14a 13/15l 4/9m
/25 0/16 0/9 1/14n 5/15o 5/11p
/25 0/16 0/9 0/14 0/15 2/9
/24 0/14 0/9 0/14 0/15 0/9
/24 0/14 0/9 0/14 0/15 0/9
/24 3/14 0/9 0/14 0/15 0/9
/24 11/14 0/9 0/14 0/15 0/9
/24 14/14 0/9 0/14 0/15 0/9
there was a 0% incidence in corn oil-treated animals of the same
severity (4 5 most severe) as described by Newbold et al. (1985).
nd age.e Mic
type
0
12
21
23
15
10
0
25
0
0
24
0
0
0
0
4
11
6
21
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235Effects of DES in the aERKO Female MouseTherefore, our observations indicate that neonatal DES
exposure in the wild-type mouse renders multiple tissues
resistant to the physiological effects of endogenous estrogen
during sexual maturity, illustrated as a lack of estrogen
stimulation in the uterus and estrogen inhibition in white
adipose tissue.
Current models of DES-related neoplasia follow the
initiation–promotion paradigm of carcinogenesis (Liehr,
2000). It is widely accepted that increased endogenous
estrogens during sexual maturation likely act in the promo-
tion of neoplasia; however, the role of genotoxic, epigenetic,
and hormonal actions of DES in tumor initiation remains
unclear (Liehr, 2000). Supporting evidence of a promotional
role of endogenous estrogens in DES carcinogenesis in-
clude: (1) clear-cell vaginal adenocarcinoma in DES daugh-
ters is predominantly diagnosed after menarche and prior to
20 years of age (Marselos and Tomatis, 1992); (2) DES-
induced uterine adenocarcinoma in CD-1 mice is prevented
by prepubertal ovariectomy (Newbold et al., 1990); and (3)
an accelerated appearance of DES-induced uterine adeno-
carcinoma in transgenic mice overexpressing ERa (Couse et
l., 1997a). Therefore, if DES-mediated initiation of tumori-
enesis is ERa-independent, perhaps via genotoxic or epi-
genetic mechanisms, but dependent on ERa actions for
anifestation, the ultimate lesions may not become appar-
nt in the aERKO. This limitation in the aERKO model as
a tool to fully discern the mechanism of DES-related
carcinogenesis must be considered. Furthermore, C57BL/6
mice, the genetic background of the aERKO used in this
study, were resistant to DES-induced neoplasms in the
female reproductive tract, consistent with previous reports
of C57BL/6 resistance to chemically induced carcinogenesis
in liver (Drinkwater and Ginsler, 1986) and lung (Festing et
al., 1998).
As generations of women exposed to DES approach
menopause, little is known of the potential health risks
associated with in utero DES exposure and ovarian senes-
cence. This may be exacerbated by potential contraindica-
tions of in utero DES exposure and pharmacological estro-
TABLE 3
Serum Estradiol Levels in Adult Wild-Type and aERKO Mice Foll
Treatment
Me
I II
Corn oil
Wild-type 21.37 6 5.9 22.48 6 2.5
aERKO 69.48 6 16.5* 48.5 6 12.5
Diethylstilbestrol
Wild-type 33.27 6 5.4 32.59 6 4.4
aERKO 47.56 6 9.4 85.25 6 47.6
Notes. Age groups are the same as in Table 1. Data shown are a
* P , 0.05; wild-type vs aERKO within the same treatment.Copyright © 2001 by Academic Press. All rightgen replacement therapy. In fact, recent epidemiologic
studies indicate the possibility of a second rise in DES-
associated vaginal clear-cell adenocarcinoma in women
over the age of 40 (Herbst, 2000). Furthermore, rodent
studies indicate that certain effects of developmental DES
exposure are transmissible to future generations via either
parent, potentially creating a second cohort of affected
individuals (Newbold et al., 1998; Turusov et al., 1992;
Walker, 1984). Finally, numerous studies have illustrated
the induction of DES-like effects in laboratory animals
following exposure to various other pharmaceutical, indus-
trial, or naturally occurring xenoestrogens (reviewed in
Golden et al., 1998; Miller and Sharpe, 1998). Therefore,
further characterization of the DES model is certain to
advance our knowledge of the potential carcinogenic and
developmental risks associated with human exposure to a
variety of xenoestrogens. Herein, we have demonstrated
that ERa is obligatory in mediating the multitude of mor-
phological and biochemical aberrations that occur in the
reproductive tract of the female mouse following neonatal
DES exposure.
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